Engro Fertilizers Q3 2026: earnings rebound, but inventory and leverage still demand attention

Verdict

Engro Fertilizers Limited (PSX: EFERT) delivered a strong third quarter on an unaudited consolidated basis. For the quarter ended September 30, 2026, net sales rose 45.3% year on year to PKR 79.59 billion, gross profit increased 56.2% to PKR 27.87 billion and profit after tax advanced 57.0% to PKR 9.12 billion. The quality of the income-statement rebound was respectable: gross margin expanded, selling and administrative costs grew more slowly than gross profit, and the calculated operating subtotal rose faster than revenue.

The balance-sheet verdict is less comfortable. Consolidated stock-in-trade more than doubled from December, borrowings increased, cash fell and nine-month operating cash flow remained negative after taxes. In other words, Q3 restored earnings momentum, but it did not yet complete the working-capital unwind that management and investors need to see. The PKR 5.50-per-share third interim dividend is meaningful, yet the cash-flow and leverage profile makes inventory conversion the central issue for the next quarter.

Results at a glance

• Reporting basis: unaudited consolidated results for the quarter and nine months ended September 30, 2026; figures below are PKR unless stated otherwise.
• Q3 net sales: PKR 79.59bn, up 45.3% from PKR 54.76bn.
• Q3 gross profit: PKR 27.87bn, up 56.2%; gross margin improved to 35.0% from 32.6%.
• Q3 calculated operating subtotal after selling/distribution and administrative expenses: PKR 19.48bn, up 73.2%; margin rose to 24.5% from 20.5%.
• Q3 profit before tax: PKR 15.81bn, up 65.1%; profit after tax: PKR 9.12bn, up 57.0%; diluted EPS: PKR 6.83 versus PKR 4.35.
• Nine-month net sales: PKR 150.44bn, up 11.1%; profit after tax: PKR 16.24bn, up 13.8%; diluted EPS: PKR 12.16 versus PKR 10.69.
• Third interim cash dividend: PKR 5.50 per share, taking announced 2026 interim dividends to PKR 9.25 per share.

AlphaGen model scores

These are AlphaGen model outputs, not company-reported financial figures:

• Alpha QoQ Score: 97.05
• TTM Performance Score: 71.61
• 3Y Business Perf Score: 54.32
• Sector Leadership Score: 55.5556

What improved

The most important change was the scale of the Q3 rebound. Sales increased by PKR 24.82bn year on year, while gross profit increased by PKR 10.03bn. Cost of sales rose 40.1%, slower than revenue, so gross margin widened by roughly 2.4 percentage points to 35.0%. That is a better result than a volume-led recovery with no margin support.

The filing does not disclose a Q3 split between urea volume, phosphates, specialty products, price and mix. It would therefore be speculative to assign the improvement to one driver. The defensible inference is that the company converted a much larger amount of product into revenue at a stronger gross margin. This follows a difficult first half in which the company reported lower urea sales, elevated inventory and pricing actions intended to absorb a relatively higher gas-cost structure. The Q3 numbers are consistent with a partial normalization, but the exact volume-price bridge remains undisclosed.

Operating leverage was also favorable. Selling and distribution expense increased 33.2% to PKR 7.09bn and administrative expense edged up only 2.4% to PKR 1.31bn. Because gross profit grew faster, the subtotal after those two expense lines climbed to PKR 19.48bn from PKR 11.24bn. Its margin improved to 24.5% from 20.5%. This is a calculated operating subtotal from the reported lines, not a separately labelled company measure.

The year-to-date picture is steadier than the quarterly jump. Nine-month sales rose 11.1% to PKR 150.44bn; gross profit grew 15.9% to PKR 51.43bn; and the corresponding gross margin improved to 34.2% from 32.8%. The calculated operating subtotal increased 16.1% to PKR 33.34bn. Profit before tax rose 17.7% and profit after tax rose 13.8%. The company therefore recovered the weak first-half trajectory strongly enough to put nine-month earnings ahead of last year.

A trailing-twelve-month check gives useful perspective. Combining the latest nine months with the implied Q4 2025 contribution produces approximately PKR 252.1bn of consolidated sales and PKR 24.6bn of profit after tax. That compares with full-year 2025 consolidated sales of PKR 237.1bn and profit after tax of PKR 22.6bn. The implied trailing net margin is about 9.8%, only modestly above 2025's 9.5%; the recovery is real, but it has not returned profitability to the stronger historical levels seen earlier in the cycle.

What weakened or needs attention

Finance cost is the clearest income-statement pressure. It rose 89.8% year on year in Q3 to PKR 2.40bn and 38.1% for nine months to PKR 5.69bn. That absorbed part of the operating improvement. The increase is consistent with a balance sheet carrying more debt and working capital, but the announcement does not provide an average-borrowing or rate bridge, so the relative contribution of higher balances and financing rates cannot be separated.

Tax also grew faster than pre-tax profit. Q3 taxation rose 77.6% to PKR 6.69bn, implying an effective tax rate of about 42.3% versus 39.3% a year earlier. Consequently, the 65.1% increase in pre-tax profit translated into a smaller 57.0% rise in net profit. For nine months, taxation increased 23.6%, faster than the 17.7% growth in profit before tax.

Below operating profit, Q3 included a PKR 217.7m loss on the subsidy receivable from the Government of Pakistan and a PKR 81.9m net remeasurement loss on Sindh Infrastructure Development Cess. The nine-month statement looks different because it contains a PKR 1.72bn net SIDC remeasurement gain, leaving total other gains of PKR 1.53bn after the subsidy-receivable loss. Readers should not treat all nine-month earnings support as recurring operating profit.

The largest balance-sheet issue is inventory. Consolidated stock-in-trade reached PKR 60.27bn at September 30 from PKR 25.69bn at December 31, an increase of about 135%. The increase is material even after allowing for the larger Q3 sales base. Trade debts fell sharply to PKR 5.07bn from PKR 16.85bn, which is positive, but other receivables rose to PKR 12.48bn and tax recoverable increased to PKR 15.33bn. Current assets of PKR 112.03bn remained below current liabilities of PKR 128.78bn, although the simple current ratio improved to about 0.87 from 0.77 at year-end.

Borrowings also moved higher. Long-term borrowings, their current portion and short-term borrowings together were approximately PKR 82.84bn, up 23.8% from PKR 66.93bn at December 2025. Cash and bank balances fell 55.0% to PKR 3.62bn. On that simple basis, net debt increased to roughly PKR 79.22bn from PKR 58.89bn. This calculation excludes other financial assets and should be read as a transparent balance-sheet indicator rather than a covenant measure.

Cash flow and capital allocation

For the nine months, cash generated from operations before the listed cash outflows was PKR 12.18bn, compared with PKR 3.06bn used in operations a year earlier. That is genuine progress. However, PKR 17.55bn of taxes paid and PKR 804m of SIDC payments meant net cash used in operating activities was still PKR 5.42bn. The comparable outflow was PKR 14.26bn, so the direction improved without yet turning positive.

Investing cash flow was nearly neutral at a PKR 62m outflow, but only after PKR 14.81bn of short-term investments and PKR 3.01bn of long-term investments were sold against PKR 18.01bn of purchases of property, plant, equipment and intangibles. Financing produced PKR 394m: substantial new long-term and short-term borrowing was largely offset by repayments, finance costs and dividends.

The PKR 5.50 third interim dividend takes announced interim dividends for 2026 to PKR 9.25 per share. The payout signals confidence in earnings, but its durability should be judged alongside operating cash conversion, the inventory unwind and the debt path rather than earnings alone.

Sector context and what the result does not prove

The Ministry of National Food Security and Research reported in June that all ten fertilizer plants were operational, national urea stocks exceeded one million tonnes and no countrywide shortage was reported. It also highlighted pressure around DAP affordability and international raw-material and supply risks. That backdrop helps explain why availability alone may not guarantee easy inventory conversion: demand, farmer economics, product pricing and imported-phosphate costs still matter.

EFERT's H1 disclosure described higher gas costs, planned pricing actions, lower company urea sales and elevated inventories. Q3's revenue and margin rebound is encouraging against that base. Still, the current announcement does not disclose Q3 production, product offtake, market share, realized price, gas consumption or segment margins. The article therefore does not claim a particular volume, pricing or mix contribution. Those are the most important gaps to resolve when the full quarterly report or corporate briefing is released.

What to monitor next

• Inventory conversion: whether stock-in-trade falls materially after the peak selling season without sacrificing gross margin.
• Debt and finance cost: whether working-capital borrowings normalize and the quarterly finance-cost run rate begins to ease.
• Cash conversion: whether operating cash flow turns positive after taxes and supports dividends and capital expenditure without further leverage.
• Urea and phosphate disclosure: Q3 volume, realized-price and mix data, plus any update on market share and channel inventory.
• Gas economics: the relative gas-cost position, supply arrangements and any policy movement toward pricing uniformity.
• One-off items: whether SIDC remeasurement or subsidy-receivable adjustments recur, and how much underlying profit remains after them.

Bottom line

EFERT's Q3 was a strong earnings quarter: higher sales, wider gross margin and disciplined operating expenses produced a 57% increase in consolidated net profit. The nine-month result is now ahead of last year, and the dividend has stepped up. But this is not yet a clean cash-led recovery. Inventory, debt and finance cost remain elevated, while the initial filing lacks the product-level bridge needed to prove exactly how much of the improvement came from volume, price or mix. The next test is straightforward: turn the Q3 income-statement rebound into lower inventory, lower leverage and positive operating cash flow.

Primary sources

• PSX: EFERT nine-month 2026 financial-results filing (October 19, 2026).

• Pakistan Stock Exchange EFERT company and filings page.

• Engro Fertilizers investor reports and presentations.

• Ministry of National Food Security and Research fertilizer-supply update (June 12, 2026).